MORGAN STANLEY - MATINAS BIOPHARMA HLDGS INC ownership

MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 57 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of MATINAS BIOPHARMA HLDGS INC
ValueSharesWeighting
Q3 2023$3,900
-63.9%
30,0010.0%0.00%
Q2 2023$10,800
-38.3%
30,001
-19.4%
0.00%
Q1 2023$17,502
-10.2%
37,239
-4.4%
0.00%
Q4 2022$19,485
+49.9%
38,968
+95.9%
0.00%
Q3 2022$13,000
-58.1%
19,887
-50.1%
0.00%
Q2 2022$31,000
-27.9%
39,869
-24.7%
0.00%
Q1 2022$43,000
-40.3%
52,967
-25.9%
0.00%
Q4 2021$72,000
+1.4%
71,475
+31.2%
0.00%
Q3 2021$71,000
+73.2%
54,459
+4.1%
0.00%
Q2 2021$41,000
-2.4%
52,324
+32.7%
0.00%
Q1 2021$42,000
-22.2%
39,425
+0.6%
0.00%
Q4 2020$54,000
+134.8%
39,204
+30.7%
0.00%
Q3 2020$23,000
+283.3%
30,000
+282.5%
0.00%
Q2 2020$6,000
-98.6%
7,843
-98.9%
0.00%
Q1 2020$429,000
+1000.0%
714,716
+4031.3%
0.00%
Q4 2019$39,000
+3800.0%
17,300
+1630.0%
0.00%
Q2 2019$1,0000.0%1,0000.0%0.00%
Q1 2019$1,000
-50.0%
1,000
-50.2%
0.00%
Q4 2018$2,0000.0%2,0070.0%0.00%
Q3 2018$2,000
-98.6%
2,007
-99.4%
0.00%
Q2 2018$139,000
+19.8%
320,845
+110.9%
0.00%
Q1 2018$116,000
-24.7%
152,147
+14.6%
0.00%
Q4 2017$154,000
+7.7%
132,818
+22.1%
0.00%
Q3 2017$143,000
+68.2%
108,807
+117.9%
0.00%
Q2 2017$85,000
-85.8%
49,945
-76.9%
0.00%
Q1 2017$600,000216,6140.00%
Other shareholders
MATINAS BIOPHARMA HLDGS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 1,429,532$1,944,0000.61%
Boxer Capital, LLC 11,478,634$15,611,0000.50%
Vivo Capital, LLC 6,451,612$8,774,0000.39%
Philadelphia Financial Management of San Francisco, LLC 740,861$1,008,0000.26%
DCF Advisers, LLC 305,299$415,0000.17%
Main Street Financial Solutions, LLC 400,826$545,0000.11%
Platform Technology Partners 158,660$216,0000.10%
STALEY CAPITAL ADVISERS INC 600,000$816,0000.05%
MONECO Advisors, LLC 50,000$81,0000.04%
CCG WEALTH MANAGEMENT, LLC 30,000$41,0000.04%
View complete list of MATINAS BIOPHARMA HLDGS INC shareholders